Cobra
Cobra agrees oncology deal with BioCancell
March 4, 2014Manufacturing and Production, Research and Development BC-821, Cobra, biocancell, oncology
Contract manufacturing organisation Cobra Biologics has signed a deal with specialist oncology biopharma firm BioCancell to manufacture an investigational cancer …
Recipharm charms Cobra shareholders into selling up
February 5, 2010Manufacturing and Production Cobra, Recipharm, Wasserburger
Swedish contract development and manufacturing organisation (CDMO) Recipharm has said that its takeover bid for UK company Cobra Biomanufacturing has …
Merck buys Avecia to boost biomanufacturing
December 21, 2009Manufacturing and Production, Research and Development Avecia Biologics, Cobra, Merck & Co, Recipharm
Merck & Co has bolstered its capabilities in biologics production with the acquisition of contract manufacturer Avecia Biologics. The deal …
Latest content
Long-acting therapies set to reshape HIV treatment market
August 21, 2026
MHRA approves Romvimza for tenosynovial giant cell tumour
August 20, 2026
